Moderna : 2024 ESCMID (mRNA-1010) - MarketScreener : vimarsana.com

Safety and Immunogenicity of an mRNA-Based


Seasonal Influenza Vaccine in Healthy Adults


Mieke Soens, Raffael...

Related Keywords

Spain , United States , Barcelona , Comunidad Autonoma De Cataluna , American , Jintanat Ananworanich , Raffael Nachbagauer , Angela Choi , Kristi Schaefers , Andrei Avanesov , Dolgine Nat , Aliscia Daniels , Alicia Pucci , Ren Chen , Bryony Hicks , Carole Henry , Mieke Soens , Greg Livermore , Exchange Commission , Centers For Disease , World Health Organization , European Congress , Moderna Inc , Influenza Vaccine , Healthy Adults , Clinical Microbiology , Infectious Diseases , Good Publication Practice , Private Securities Litigation Reform Act , Annual Report , Based Seasonal Influenza Vaccine Candidate , World Health , Wkly Epidemiol , Rev Drug , Disease Control , Vaccine Effectiveness , How Well Do Flu Vaccines , Active Controlled Study Evaluating , Northern Hemisphere , All Primary Immunogenicity End Points , Mean Ratios , Active Comparator , Rate Differences , Markets ,